But warm reminder: these funds have performed a little too well recently and may weaken in the next stage.

Because it is impossible for heavy stocks to keep rising, please note that in the first few months of the fixed investment, one or two may quickly fall to the countdown, if heavy stocks quickly retreat their gains.

There is nothing to say about the return of China. Has been doing well, definitely worth holding!

Shangtou's recent performance is very hot. Thanks to the surge of small-cap stocks in emerging industries, fund managers are also good at stock selection, but we should pay attention to the risk of small-cap stocks falling into a downturn.

E Fund Medical, an industry fund, is relatively risky. At the beginning of the year, the pharmaceutical industry took a long time and its performance was in the forefront. But I personally think that the increase is somewhat overdrawn and there is not much room for growth. Moreover, pharmaceutical stocks are weak and strong. If the market continues to slump, they can hold it. Once they rise, it is estimated that their performance will not be good.

Personal opinion, for reference only, welcome to discuss!